19-10994889-C-T

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBP6

The NM_001387283.1(SMARCA4):​c.1481C>T​(p.Thr494Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000479 in 1,461,786 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T494T) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 0.0000048 ( 0 hom. )

Consequence

SMARCA4
NM_001387283.1 missense

Scores

2
4
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: 3.42

Publications

0 publications found
Variant links:
Genes affected
SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
SMARCA4 Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
  • intellectual disability, autosomal dominant 16
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • rhabdoid tumor predisposition syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • uterine corpus sarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • familial rhabdoid tumor
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.18553635).
BP6
Variant 19-10994889-C-T is Benign according to our data. Variant chr19-10994889-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 408682.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMARCA4NM_001387283.1 linkc.1481C>T p.Thr494Ile missense_variant Exon 9 of 36 ENST00000646693.2 NP_001374212.1
SMARCA4NM_003072.5 linkc.1481C>T p.Thr494Ile missense_variant Exon 9 of 35 ENST00000344626.10 NP_003063.2 P51532-1A7E2E1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMARCA4ENST00000646693.2 linkc.1481C>T p.Thr494Ile missense_variant Exon 9 of 36 NM_001387283.1 ENSP00000495368.1 Q9HBD4
SMARCA4ENST00000344626.10 linkc.1481C>T p.Thr494Ile missense_variant Exon 9 of 35 1 NM_003072.5 ENSP00000343896.4 P51532-1
SMARCA4ENST00000643549.1 linkc.1481C>T p.Thr494Ile missense_variant Exon 9 of 35 ENSP00000493975.1 A0A2R8Y4P4
SMARCA4ENST00000541122.6 linkc.1481C>T p.Thr494Ile missense_variant Exon 10 of 35 5 ENSP00000445036.2 P51532-4
SMARCA4ENST00000643296.1 linkc.1481C>T p.Thr494Ile missense_variant Exon 9 of 34 ENSP00000496635.1 P51532-4
SMARCA4ENST00000644737.1 linkc.1481C>T p.Thr494Ile missense_variant Exon 9 of 34 ENSP00000495548.1 P51532-4
SMARCA4ENST00000589677.5 linkc.1481C>T p.Thr494Ile missense_variant Exon 10 of 35 5 ENSP00000464778.1 P51532-3
SMARCA4ENST00000643995.1 linkc.893C>T p.Thr298Ile missense_variant Exon 6 of 32 ENSP00000496004.1 A0A2R8YGG3
SMARCA4ENST00000644963.1 linkc.125C>T p.Thr42Ile missense_variant Exon 2 of 28 ENSP00000495599.1 A0A2R8YG32
SMARCA4ENST00000644065.1 linkc.209C>T p.Thr70Ile missense_variant Exon 2 of 27 ENSP00000493615.1 A0A2R8Y440
SMARCA4ENST00000642350.1 linkc.-32C>T upstream_gene_variant ENSP00000495355.1 A0A2R8Y6N0

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
AF:
0.00000479
AC:
7
AN:
1461786
Hom.:
0
Cov.:
31
AF XY:
0.00000275
AC XY:
2
AN XY:
727212
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33478
American (AMR)
AF:
0.00
AC:
0
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000540
AC:
6
AN:
1111916
Other (OTH)
AF:
0.00
AC:
0
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
31
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Intellectual disability, autosomal dominant 16 Uncertain:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Rhabdoid tumor predisposition syndrome 2 Uncertain:1
May 08, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 494 of the SMARCA4 protein (p.Thr494Ile). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SMARCA4-related conditions. ClinVar contains an entry for this variant (Variation ID: 408682). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SMARCA4 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not provided Uncertain:1
Jun 09, 2023
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 24658002) -

Hereditary cancer-predisposing syndrome Benign:1
Oct 25, 2023
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.57
BayesDel_addAF
Uncertain
0.048
T
BayesDel_noAF
Benign
-0.17
CADD
Uncertain
24
DANN
Uncertain
0.98
DEOGEN2
Benign
0.32
T;.;T;.;.;.;.;.;.;.;T;.;.;.;.;.;T;T;.
Eigen
Benign
-0.19
Eigen_PC
Benign
-0.011
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.91
.;D;.;.;.;.;D;.;.;.;D;.;D;D;D;D;D;D;D
M_CAP
Benign
0.036
D
MetaRNN
Benign
0.19
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-1.4
N;.;.;.;N;N;.;N;N;N;N;N;N;N;N;N;.;.;.
PhyloP100
3.4
PrimateAI
Pathogenic
0.85
D
PROVEAN
Benign
-1.2
N;.;.;.;.;.;.;.;.;.;N;.;N;.;N;.;N;N;.
REVEL
Benign
0.17
Sift
Benign
0.30
T;.;.;.;.;.;.;.;.;.;T;.;T;.;T;.;T;T;.
Sift4G
Benign
0.43
T;.;.;.;.;.;.;.;.;.;T;.;T;T;T;T;T;T;.
Polyphen
0.073
B;.;B;.;.;.;.;.;.;.;B;.;.;.;.;.;.;B;.
Vest4
0.27
MutPred
0.48
Gain of catalytic residue at T494 (P = 0.0068);Gain of catalytic residue at T494 (P = 0.0068);Gain of catalytic residue at T494 (P = 0.0068);Gain of catalytic residue at T494 (P = 0.0068);Gain of catalytic residue at T494 (P = 0.0068);Gain of catalytic residue at T494 (P = 0.0068);Gain of catalytic residue at T494 (P = 0.0068);Gain of catalytic residue at T494 (P = 0.0068);Gain of catalytic residue at T494 (P = 0.0068);Gain of catalytic residue at T494 (P = 0.0068);Gain of catalytic residue at T494 (P = 0.0068);Gain of catalytic residue at T494 (P = 0.0068);Gain of catalytic residue at T494 (P = 0.0068);Gain of catalytic residue at T494 (P = 0.0068);Gain of catalytic residue at T494 (P = 0.0068);Gain of catalytic residue at T494 (P = 0.0068);Gain of catalytic residue at T494 (P = 0.0068);Gain of catalytic residue at T494 (P = 0.0068);.;
MVP
0.75
MPC
2.4
ClinPred
0.78
D
GERP RS
4.5
PromoterAI
0.010
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.27
gMVP
0.95
Mutation Taster
=15/85
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1060502098; hg19: chr19-11105565; API